Updates are available Correction dated 2022-03-19
Click to view Correction: https://doi.org/10.1245/s10434-022-11602-4
-
Authors
Nessim, Carolyn
Raut, Chandrajit P.
Callegaro, Dario
Barretta, Francesco
Miceli, Rosalba
Fairweather, Mark
Rutkowski, Piotr
Blay, Jean-Yves
Strauss, Dirk
Gonzalez, Ricardo
Ahuja, Nita
Grignani, Giovanni
Quagliuolo, Vittorio
Stoeckle, Eberhard
De Paoli, Antonino
Pillarisetty, Venu G.
Swallow, Carol J.
Bagaria, Sanjay P.
Canter, Robert J.
Mullen, John T.
Schrage, Yvonne
Pennacchioli, Elisabetta
van Houdt, Winan
Cardona, Kenneth
Fiore, Marco
Gronchi, Alessandro
Lahat, Guy
- License Information
-
More Information
Article History
Received: 13 June 2020
Accepted: 13 October 2020
First Online: 2 January 2021
Change Date: 19 March 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1245/s10434-022-11602-4
Disclosure
: Dr. Nita Ahuja has received grant funding from Cepheid and Astex and has served as consultant to Ethicon. She has licensed methylation biomarkers to Cepheid. Dr. Giovanni Grignani has received grants from Pharmamar, Bayer, Novartis Board participation, Pharmamar, Bayer, Novartis, Pfizer, EISAI, and Merck. The remaining authors have no conflicts of interest.
